- Company Overview for KELSO PHARMA LIMITED (SC678102)
- Filing history for KELSO PHARMA LIMITED (SC678102)
- People for KELSO PHARMA LIMITED (SC678102)
- More for KELSO PHARMA LIMITED (SC678102)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
11 Nov 2024 | CS01 | Confirmation statement made on 29 October 2024 with no updates | |
20 Mar 2024 | AA | Accounts for a dormant company made up to 31 December 2023 | |
09 Nov 2023 | CS01 | Confirmation statement made on 29 October 2023 with no updates | |
03 Feb 2023 | AA | Accounts for a dormant company made up to 31 December 2022 | |
31 Oct 2022 | CS01 | Confirmation statement made on 29 October 2022 with updates | |
25 Apr 2022 | AA | Micro company accounts made up to 31 December 2021 | |
02 Nov 2021 | AA01 | Current accounting period extended from 31 October 2021 to 31 December 2021 | |
29 Oct 2021 | CS01 | Confirmation statement made on 29 October 2021 with updates | |
05 Mar 2021 | PSC01 | Notification of Andrew Firth Mclean as a person with significant control on 6 January 2021 | |
05 Mar 2021 | PSC01 | Notification of Allan Mark Watson as a person with significant control on 6 January 2021 | |
05 Mar 2021 | PSC04 | Change of details for Dr Harry Thomas Stratford as a person with significant control on 5 March 2021 | |
07 Jan 2021 | SH01 |
Statement of capital following an allotment of shares on 6 January 2021
|
|
07 Jan 2021 | AP01 | Appointment of Allan Mark Watson as a director on 6 January 2021 | |
07 Jan 2021 | AP01 | Appointment of Mr Andrew Firth Mclean as a director on 6 January 2021 | |
20 Oct 2020 | NEWINC |
Incorporation
Statement of capital on 2020-10-20
|